Rapid determination of natural steroidal hormones in saliva for the clinical diagnoses
© Oh et al 2012
Received: 17 February 2012
Accepted: 28 March 2012
Published: 28 March 2012
Saliva samples are easily collectable and non-invasive, and the monitoring of natural steroidal hormones, such as estrone (E1), 17β-estradiol (E2), estriol (E3), progesterone (P), and testosterone (T), in saliva has attracted much attention due to its numerous potential clinical and health-related applications. Because E1, E2, E3, P and T are useful indicators in numerous clinical and health-related diagnoses, there is a need for simultaneous determination.
A gas chromatography-mass spectrometric assay was developed for rapid simultaneous determination of E1, E2, E3, P and T in saliva for clinical diagnoses. Extraction was achieved with a liquid extraction using 3.0 mL of pentane. The extract was dried and silylated with N-methyl-N-(trimethylsilyl) trifluoroacetamide/NH4I (100:2) under a catalysis of 1.5% dithioerythritol for 10 min at 90°C. The accuracy of the analytes was in the range of 96% to 112% at concentrations of 0.05 and 0.10 μg/L (5.0 and 10.0 μg/L for E3), respectively, with relative standard deviations of less than 11%. The lowest quantification limits were from 0.002 to 0.6 μg/L for 1.0 mL of saliva.
Natural steroidal hormones were detected in the concentration ranges of nd to 0.2 μg/L in human saliva. The salivary testosterone values in the patients with prostatic carcinoma were significantly lower than in normal males. The method may useful in numerous clinical and health-related diagnoses.
KeywordsClinical diagnosis Natural steroidal hormones Saliva GC-MS
Saliva samples are easily collectable, non-invasive, and pose no risk to the health of the subjects. Salivary concentrations of steroids generally reflect serum concentrations of free active steroids; a significant correlation between salivary and serum steroid concentrations was shown in men [1–4]. Therefore, saliva has been used in a number of human and nonhuman studies to determine the presence of a wide range of substances, including biological substances and pharmaceutical drugs . The monitoring of natural steroidal hormones, such as estrone (E1), 17β-estradiol (E2), estriol (E3), progesterone (P), and testosterone (T), in saliva has attracted much attention due to its numerous potential clinical and health-related applications [1–4, 6–14].
Clinical monitoring of E2 is desirable for the study and treatment of hormone-dependent carcinomas , and investigating ovarian function . The measurement of salivary E3 concentrations could be useful in evaluating antidepressant use during pregnancy  and the simultaneous measurement of salivary E3 and P concentrations could be useful in the prediction of preterm birth . Measurement of salivary E1 and salivary T could give useful information in evaluating of pregnant sows , and the androgenic function of patients with prostatic carcinoma after medical or surgical orchiectomy  and late-onset hypogonadism [11, 12], respectively. Monitoring T in children's saliva affords a unique view of the effects of behavioral factors on development .
Many analytical procedures have been proposed to determine trace level for natural steroidal compounds in saliva, most of which are based on determining E1 , E2 , E3 [17, 18], P , and T  levels in saliva using enzyme immunoassay. Although this technique will continue to be the method of choice for routine use in clinical fields, especially in large population-based tests, it does not have a simultaneous multianalyte quantification capability.
Recently, liquid chromatography-tandem mass spectrometric (LC-MS/MS) methods has been developed and validated for the quantification of salivary T [4, 12, 20, 21]. These methods are restrictive for the quantification of salivary T, and require complicated clean-up procedures and expensive instruments.
Several researchers have analyzed the salivary T in human saliva using a gas chromatography-mass spectrometry after the t-butyldimethylsilyl ether and methyl oxime, t-butyldimethylsilyl ether derivatization [22, 23]. These methods are also restrictive for the quantification of salivary T, and require immunoadsorption as sample treatment. Silylation is a versatile method used to derivatize the organic compounds that contain the hydroxyl group to enhance the GC-MS properties. Reduction of reaction time may be more effective in determining the natural steroids in saliva.
The purpose of the present study is to develop a sensitive and simultaneous determination method for natural steroidal hormones (E1, E2, E3, P and T) in saliva and to evaluate the increased risk of various disorders.
Chemicals and reagents
The following chemicals were purchased from Sigma (St. Louis, MO, USA): estrone, 17β-estradiol, estriol, progesterone, testosterone, testosterone-d3, dithioerythritol, NH4I and N-methyl-N-(trimethylsilyl) trifluoroacetamide (MSTFA). For the reagent, analytical grade sodium sulfate (Sigma, St. Louis, MO, USA) was used. Acetonitrile and pentane (E. Merck, Darmstadt, Germany) were used for the solvents.
Collection and extraction procedure of saliva
The study was approved by the institutional review board at the Kongju national university, and written informed consent was obtained from each subject. Saliva (ca. 1.2 mL) was directly collected into a collecting tube (without a collection device) from 10 volunteers who did not take hormone supplements or drugs that influence steroid hormone biosynthesis and metabolism. The volunteers did not smoke, eat and drink or brush their teeth within 1 h prior to the sample collection. Saliva (ca. 1.2 mL) was also taken from five patients with prostatic carcinoma under the treatment in a University Hospital (Dejoen, Korea). The sample collection time was between ten and eleven o'clock in the morning. It was stored in a glass collection tube below -20°C until use. After thawing, a 1.0 mL sample was placed in a 10 mL test tube and 25.0 μL of a testosterone-d3 internal standard solution (10.0 μg/L in acetonitrile) was added to the solution. The solution was extracted with 3.0 mL of pentane by subjecting the mixture to vortex mixing for 1 min after adding 3.0 g of dried sodium sulfate. The organic phase was dried in nitrogen stream.
The dry residue was dissolved with 50 μL of silylating reagents (MSTFA + 2.0% NH4I + 1.5% dithioerythritol, v/w/w) and the tubes were heated for 10 min at 90°C, and a 2 μL sample of the solution was injected into the GC system.
Gas chromatography-mass spectrometry
All mass spectra were obtained with an Agilent 6890/5975 instrument. The ion source was operated in the electron ionization mode (EI; 70 eV, 230°C). Full-scan mass spectra (m/z 40-800) were recorded for the analyte identification. Separation was achieved with a HP fused-silica capillary column with a cross-linked 5% phenyl methylsilicone (DB 5); the column has a length of approximately 30 m, an inner diameter of 0.25 mm and a film thickness of 0.25 μm. Samples were injected in a splitless mode. The flow rate of the helium was 1.0 mL/min.
The operating parameters were as follows: injector temperature, 310°C; transfer line temperature, 300°C; and oven temperature, programmed from 150°C at 12°C/min to 310°C (hold for 4 min). The ions that were selected for monitoring by the SIM were m/z 414, 399 and 309 for E1, m/z 416, 326 and 285 for E2, m/z 504, 345 and 311 for E3, m/z 458, 443 and 157 for P, m/z 432, 417, and 208 for T, and m/z 435, 420, and 209 for T-d3 (internal standard).
Calibration and quantification
The calibration curves for the E1, E2, E3, P and T were established through extraction and derivatization after the addition of 0.002, 0.010, 0.025, 0.050 and 0.10 ng/mL of the standards and 0.25 ng/mL of the internal standard into 1.0 mL of saliva. Saliva (ca. 1.2 mL) for the calibration curve was collected from healthy volunteer, who did not smoke, eat and drink or brush their teeth within 1 h prior to the sample collection. The ratio of the standard peak area to that of the internal standard was used in the quantification of the compound. The quantification ion was m/z 414 for E1, m/z 416 for E2, m/z 504 for E3, m/z 458 for P, m/z 432 for T, and m/z 435 for T-d3 (internal standard)
Results and discussion
Molecular formula and mass of target compounds and their derivatives
Corresponding Derivative Products
To develop a rapid derivatization method of steroids with multi-functional groups, the first attempt located the condition in order to silylate only at the hydroxyl group of the steroid under mild condition using MSTFA. However, it was unsuccessful because the derivatization was not quantitative. Furthermore, an attempt to develop a rapid derivatization method for all functional groups of steroids by changing the amount of catalyzing agents, the reaction temperature, and reaction time was also undertaken. The MSTFA as a silylating reagent and NH4-I/dithioerythritol as catalyzing agents were tested in terms of the reactivity of the derivatives. The derivatization was performed for various NH4-I and dithioerythritol concentrations (0.3, 1.0, 1.5, 2.0, 3.0, 4.0 and 5.0 wt % to MSTFA weight). The rapid derivatization was reached with 2.0% of NH4-I and 1.5% of dithioerythritol and the yield remained beyond the catalyzing agent amount.
The derivatives were analyzed at reaction times of 10, 20, 30, 40 and 60 min at 85, 90 and 95°C. When the reaction temperature and time increased to 90°C and 10 min, the derivatization yield achieved its maximum.
As a result, the steroids showed a rapid and complete reaction in 10 min at 90°C with MSTFA/NH4-I (100:2) containing 1.5% dithioerythritol. A ketone group of E1 and T, and two ketone groups of P were completely converted to TMS-enol in 10 min in these conditions.
Mass fragmentation of steroid derivatives
Liquid-liquid extraction (LLE) with pentane was selected for the rapid extraction of steroids in saliva and the use of dried sodium sulfate in the sample allow the most water to remove from the sample, to increase the recovery of steroids from the saliva, and to decant the organic phase without centrifugation. The total sample treatment time including derivatization was reduced to 20 min.
Method validation results of the target compounds
Precision and Accuracy (n = 5)
(n = 5)
Spiked Conc (μg L-1)
y = 0.0707x - 0.0001
104 ± 7.4
105 ± 5.9
y = 0.0768x + 0.0003
93.0 ± 10.0
106 ± 5.0
y = 0.3431x + 0.0002
111 ± 8.7
94.4 ± 7.9
y = 0.0315x + 0.0003
98.6 ± 6.0
105 ± 3.3
y = 0.1738x + 0.0037
101 ± 4.2
108 ± 4.8
A linear relation with an average correlation coefficient of 0.999 was found in the examination of a typical standard curve. A least squares fit was used to compute the regression line of the peak area ratios of the bis-TMS-E1, bis-TMS-E2, tri-TMS-E3, bis-TMS-P and bis-TMS-T to bis-TMS-T-d3 on concentrations. Table 3 shows the lines of the best fit and the correlation coefficients for the steroids.
Table 3 confirms that the reproducibility of the assay was very good. For the five independent determinations at 0.05 and 0.10 μg/L, the coefficient of variation was less than 11%.
Comparison of analytical methods for determining natural steroidal compounds in saliva
The limit of quantification (μg/L)
Hogg et al. 2005 
Matsui et al. 2009 
Shibayama et al. 2009 
Gould et al. 1986 
De Boever et al. 1988 
Kivlighan et al. 2005 
Real sample analysis
The target compounds in 10 healthy volunteer and 5 patient saliva samples were analyzed. Confirmation of trace analytes was achieved by use of three characteristic MS ions. The characteristic ion ratios and GC retention times were matched with those of standard compounds.
Analytical results of natural steroidal hormones in saliva
Age range (Mean Age)
Analytical results, mean ± SD (ng/L)
11 ± 3
17 ± 7
37 ± 3
116 ± 49
Patient with prostatic carcinoma
12 ± 9
The salivary T concentrations of healthy volunteers were in a range of 0.032 to 0.040 μg/L in the female subjects, and in a range of 0.077 to 0.200 μg/L in the male subjects in this study. Otherwise, testosterone concentrations in saliva 5 patients with prostatic carcinoma were measured in a range of not detected to 0.027 μg/L. The salivary testosterone values in these patients were significantly lower than in normal males. The proposed method also has sufficient sensitivity for the estimate of the androgenic function of patients with prostatic carcinoma.
E1 and E3 were not detected in any saliva samples in this study. The normal concentration range fell below the detectability levels of this method. Heine et al. reported that an E3 measurement of 2.1 μg/L predicted an increased risk of preterm labor and delivery . Elevated levels of estriol (0.9-2.1 μg/L) are an indication of preterm births  and show higher than LOQ (0.3 μg/L) of E3 using the proposed method. The results suggest that the measurement of salivary E3 concentration using the proposed method can evaluate the increased risk of preterm labor and delivery.
Thus, it is concluded that the simultaneous monitoring of E1, E2, E3, P, and T using the proposed method can evaluate the increased risk of many hormone dependant disorders.
A sensitive and simultaneous method has been developed to analyze natural steroids in human saliva. The silylation derivatives of steroids containing multifunctional groups with MSTFA/NH4I (100:2) containing dithioerythritol for 10 min at 90°C have good chromatographic properties and offer a single derivative product. The extraction of these compounds from saliva with pentane and dried sodium sulfate yields a high rate of recovery with a small degree of variation. Furthermore, the quantification of the steroids is excellent. The linear calibration curves cover a range of LOQ to 100 μg/L, and the LOQs are 0.002 to 0.3 μg/L for a 1.0 mL sample of saliva. The natural steroids present in saliva were determined. In the present study, the suggested method enables the successful determination of trace amounts of natural steroidal compounds in saliva. The results suggest that the measurement of salivary E1, E2, E3, P, and T concentrations using the proposed method can evaluate the increased risk of various disorders.
- Arregger AL, Contreras LN, Tumilasci OR, Aquilano DR, Cardoso EML: Salivary testosterone: a reliable approach to the diagnosis of male hypogonadism. Clin Endocrinol. 2007, 67: 656-662. 10.1111/j.1365-2265.2007.02937.x.View ArticleGoogle Scholar
- Cardoso E, Persi G, Gonzalez N: Assessment of adrenal function by measurement of salivary steroids in response to corticotrophin in patients infected with human immunodeficiency virus. Steroids. 2007, 72: 328-334. 10.1016/j.steroids.2006.12.003.View ArticleGoogle Scholar
- Yasuda M, Honma S, Furuya K: Diagnostic significance of salivary testosterone measurement revisited: using liquid chromatography/mass spectrometry and enzyme-linked immunosorbent assay. J Men Heal. 2008, 5: 56-63. 10.1016/j.jomh.2007.12.004.View ArticleGoogle Scholar
- Shibayama Y, Higashi T, Shimada K: Simultaneous determination of salivary testosterone and dehydroepiandrosterone using LC-MS/MS: Method development and evaluation of applicability for diagnosis and medication for late-onset hypogonadism. J Chromatogr B. 2009, 877: 2615-2623. 10.1016/j.jchromb.2008.10.051.View ArticleGoogle Scholar
- Kaufman E, Lamster IB: The diagnostic applications of saliva-a review. Crit Rev Oral Biol Med. 2002, 13: 197-212. 10.1177/154411130201300209.View ArticleGoogle Scholar
- Worthman CM, Stallings JF, Hofman LF: Sensitive salivary estradiol assay for monitoring ovarian function. Clin Chem. 1990, 36: 1769-1773.Google Scholar
- Suri R, Hellemann G, Cohen L: Saliva estriol levels in women with and without prenatal antidepressant treatment. Biol Psych. 2008, 64: 533-553. 10.1016/j.biopsych.2008.04.015.View ArticleGoogle Scholar
- Klebanoff MA, Meis PJ: Salivary progesterone and estriol among pregnant women treated with 17-α-hydroxyprogesterone caproate or placebo. Am J Obstet Gynecol. 2008, 199: 506e1-506e7.View ArticleGoogle Scholar
- Ohtaki T, Moriyoshi M, Nakada K: Radioimmunoassay of saliva estrone sulfate in pregnant sows. J Vet Med Sci. 1997, 59: 759-763. 10.1292/jvms.59.759.View ArticleGoogle Scholar
- Navarro MA, Aguiló FB: Salivary testosterone in prostatic carcinoma. J Urol. 1989, 63: 306-308. 10.1111/j.1464-410X.1989.tb05194.x.View ArticleGoogle Scholar
- Yasuda M, Furuya K, Yoshii T: Low testosterone level of middle-aged Japanese men - the association between low testosterone levels and quality-of-life. J Men Heal. 2007, 4: 149-155.Google Scholar
- Matsui F, Eitetsu K, Kenrou Y: Liquid chromatography-tandem mass spectrometry (LC-MS/MS) assay for simultaneous measurement of salivary testosterone and cortisol in healthy men for utilization in the diagnosis of late-onset hypogonadism in males. Endocrine J. 2009, 56: 1083-1094. 10.1507/endocrj.K09E-186.View ArticleGoogle Scholar
- Jensen MA, Hansen AM, Abrahamsson P: Development and evaluation of a liquid chromatography tandem mass spectrometry method for simultaneous determination of salivary melatonin, cortisol and testosterone. J Chromatogr B. 2011, 25: 2527-2532.View ArticleGoogle Scholar
- Ives SJ, Blegen M, Coughlin MA: Salivary estradiol, interleukin-6 production, and the relationship to substrate metabolism during exercise in females. Eur J Appl Physiol. 2011, 8: 1649-1658.View ArticleGoogle Scholar
- Dabbs JM: Salivary testosterone measurements: Reliability across hours, days, and weeks. Phys Behav. 1990, 48: 83-86. 10.1016/0031-9384(90)90265-6.View ArticleGoogle Scholar
- Kivlighan KT, Granger DA, Schwartz EB: Blood contamination and the measurement of salivary progesterone and estradiol. Horm Behav. 2005, 47: 367-370. 10.1016/j.yhbeh.2004.12.001.View ArticleGoogle Scholar
- Voss H: Saliva as a fluid for measurement of estriol levels. Am J Obstet Gynecol. 1999, 180: S226-S231. 10.1016/S0002-9378(99)70706-4.View ArticleGoogle Scholar
- De Boever J, Ulrix W, Vandekerckhove D: Direct chemiluminescence immuoassay of estriol and progresterone and their ratio during pregnancy. Chemluminescence immunoassay for estriol in saliva. Anal Chim Acta. 1998, 205: 215-222.View ArticleGoogle Scholar
- Johnson SG, Joplin GF, Burrin JM: Direct assay for testosterone in saliva: Relationship with a direct serum free testosterone assay. Clin Chim Acta. 1987, 163: 309-318. 10.1016/0009-8981(87)90249-X.View ArticleGoogle Scholar
- Nobuyuki K, Ikeda K, Honma S: Validation of salivary cortisol and testosterone assays in chimpanzees by liquid chromatography-tandem mass spectrometry. Am J Primat. 2009, 71: 696-706. 10.1002/ajp.20708.View ArticleGoogle Scholar
- Hogg CJ, Vickers ER, Rogers TL: Determination of testosterone in saliva and blow of bottlenose dolphins (Tursiops truncatus) using liquid chromatography-mass spectrometry. J Chromatogr B. 2005, 814: 339-346. 10.1016/j.jchromb.2004.10.058.View ArticleGoogle Scholar
- Gaskell SJ, Pike AW, Griffiths K: Analysis of testosterone and dehydroepiandrosterone in saliva by gas chromatography-mass spectrometry. Steroids. 1980, 36: 219-228. 10.1016/0039-128X(80)90020-3.View ArticleGoogle Scholar
- Gould VJ, Turkes AO, Gaskell S: Gas chromatography-mass spectrometric analysis of salivary testosterone with reference to diethylstilboestrol-treated prostatic cancer patients. J Steroid Biochem. 1986, 24: 563-567. 10.1016/0022-4731(86)90120-2.View ArticleGoogle Scholar
- Heine RP, McGregor JA, Goodwin TM, Artal R, Hayashi RH, Robertson PA, Varner MW: Serial salivary estriol to detect an increased risk of preterm birth. Obstet Gynecol. 2000, 96: 490-497. 10.1016/S0029-7844(00)01004-8.Google Scholar